COMP and cancer: COMP is a cancer biomarker and is useful in staging the progressive/poor prognosis/cancer remission phases of diseases including colon, prostate, pancreas, stomach and rectal adenocarcinomas, lymphoid neoplasms, diffuse large B-cell lymphoma, and kidney and ovarian adenocarcinomas.